These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 26424146

  • 1. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
    Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker TP, Blackwell TS, Yull FE.
    BMC Cancer; 2015 Sep 30; 15():647. PubMed ID: 26424146
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden.
    Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, Blackwell TS, Yull FE.
    Oncogene; 2011 Mar 24; 30(12):1402-12. PubMed ID: 21076466
    [Abstract] [Full Text] [Related]

  • 3. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
    Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE.
    Cancer Res; 2001 May 01; 61(9):3810-8. PubMed ID: 11325857
    [Abstract] [Full Text] [Related]

  • 4. β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.
    Nam JM, Ahmed KM, Costes S, Zhang H, Onodera Y, Olshen AB, Hatanaka KC, Kinoshita R, Ishikawa M, Sabe H, Shirato H, Park CC.
    Breast Cancer Res; 2013 May 01; 15(4):R60. PubMed ID: 23883667
    [Abstract] [Full Text] [Related]

  • 5. The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
    Bennett L, Mallon EA, Horgan PG, Paul A, McMillan DC, Edwards J.
    Oncotarget; 2017 May 16; 8(20):33002-33013. PubMed ID: 28423692
    [Abstract] [Full Text] [Related]

  • 6. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
    Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE.
    Cancer Res; 2005 Dec 15; 65(24):11375-83. PubMed ID: 16357145
    [Abstract] [Full Text] [Related]

  • 7. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM.
    Cancer Res; 2000 Nov 15; 60(22):6488-95. PubMed ID: 11103818
    [Abstract] [Full Text] [Related]

  • 8. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK, Iglehart JD.
    J Cell Physiol; 2006 Dec 15; 209(3):645-52. PubMed ID: 17001676
    [Abstract] [Full Text] [Related]

  • 9. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
    Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE.
    Mol Cell Biol; 2005 Nov 15; 25(22):10136-47. PubMed ID: 16260626
    [Abstract] [Full Text] [Related]

  • 10. Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection.
    Connelly L, Barham W, Pigg R, Saint-Jean L, Sherrill T, Cheng DS, Chodosh LA, Blackwell TS, Yull FE.
    J Cell Physiol; 2010 Jan 15; 222(1):73-81. PubMed ID: 19746431
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
    Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB.
    Breast Cancer Res Treat; 1999 May 15; 55(2):179-88. PubMed ID: 10481945
    [Abstract] [Full Text] [Related]

  • 12. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
    Seth A, Kitching R, Landberg G, Xu J, Zubovits J, Burger AM.
    Anticancer Res; 2003 May 15; 23(3A):2043-51. PubMed ID: 12894577
    [Abstract] [Full Text] [Related]

  • 13. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.
    Erez N, Glanz S, Raz Y, Avivi C, Barshack I.
    Biochem Biophys Res Commun; 2013 Aug 02; 437(3):397-402. PubMed ID: 23831470
    [Abstract] [Full Text] [Related]

  • 14. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.
    Lian K, Ma C, Hao C, Li Y, Zhang N, Chen YH, Liu S.
    Oncotarget; 2017 Jul 25; 8(30):48889-48904. PubMed ID: 28388580
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory cytokine-enriched microenvironment plays key roles in the development of breast cancers.
    Takeuchi Y, Gotoh N.
    Cancer Sci; 2023 May 25; 114(5):1792-1799. PubMed ID: 36704829
    [Abstract] [Full Text] [Related]

  • 16. Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.
    Turner-Ivey B, Smith EL, Rutkovsky AC, Spruill LS, Mills JN, Ethier SP.
    Breast Cancer Res Treat; 2017 Jul 25; 164(2):349-358. PubMed ID: 28484924
    [Abstract] [Full Text] [Related]

  • 17. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
    Shin SR, Sánchez-Velar N, Sherr DH, Sonenshein GE.
    Cancer Res; 2006 Mar 01; 66(5):2570-5. PubMed ID: 16510574
    [Abstract] [Full Text] [Related]

  • 18. Influence of autocrine growth hormone on NF-κB activation leading to epithelial-mesenchymal transition of mammary carcinoma.
    Baskari S, Govatati S, Madhuri V, Nallabelli N, K PM, Naik S, Poornachandar, Balka S, Tamanam RR, Devi VR.
    Tumour Biol; 2017 Oct 01; 39(10):1010428317719121. PubMed ID: 29022487
    [Abstract] [Full Text] [Related]

  • 19. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb 01; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 20. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
    Krstic M, Macmillan CD, Leong HS, Clifford AG, Souter LH, Dales DW, Postenka CO, Chambers AF, Tuck AB.
    BMC Cancer; 2016 Aug 23; 16(1):671. PubMed ID: 27553211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.